Annual hazard rates of recurrence for breast cancer after primary therapy.
作者： T Saphner , D C Tormey , R Gray
DOI: 10.1200/JCO.1996.14.10.2738
关键词: Primary therapy 、 Entire population 、 Adjuvant therapy 、 Surgery 、 Hazard 、 Breast cancer 、 Internal medicine 、 Medicine
摘要: PURPOSE To determine if the long-term increase of recurrence for breast cancer is stable or slowly decreasing, or if it ever reaches zero; and to determine the effect of prognostic …
sci-hub.se 参考文章(19)
C A Quiet, D J Ferguson, R R Weichselbaum, S Hellman, Natural history of node-negative breast cancer: a study of 826 patients with long-term follow-up. Journal of Clinical Oncology. ,vol. 13, pp. 1144- 1151 ,(1995) , 10.1200/JCO.1995.13.5.1144
F J Cummings, R Gray, D C Tormey, T E Davis, H Volk, J Harris, G Falkson, J M Bennett, Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death. Journal of Clinical Oncology. ,vol. 11, pp. 29- 35 ,(1993) , 10.1200/JCO.1993.11.1.29
D C Tormey, R Gray, M D Abeloff, D L Roseman, K W Gilchrist, E J Barylak, P Stott, G Falkson, Adjuvant therapy with a doxorubicin regimen and long-term tamoxifen in premenopausal breast cancer patients: an Eastern Cooperative Oncology Group trial. Journal of Clinical Oncology. ,vol. 10, pp. 1848- 1856 ,(1992) , 10.1200/JCO.1992.10.12.1848
Douglass C. Tormey, Robert Gray, Kennedy Gilchrist, Theodore Grage, Paul P. Carbone, Janet Wolter, Judith E. Woll, Frank J. Cummings, Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An eastern cooperative oncology group trial Cancer. ,vol. 65, pp. 200- 206 ,(1990) , 10.1002/1097-0142(19900115)65:2<200::AID-CNCR2820650203>3.0.CO;2-Q
C. BARBER MUELLER, WENDY JEFFRIES, Cancer of the breast: Its outcome as measured by the rate of dying and causes of death. Annals of Surgery. ,vol. 182, pp. 334- 341 ,(1975) , 10.1097/00000658-197509000-00016
W Duncan, G R Kerr, The curability of breast cancer. BMJ. ,vol. 2, pp. 781- 783 ,(1976) , 10.1136/BMJ.2.6039.781
Lars Erik Rutqvist, Arne Wallgren, Long-term survival of 458 young breast cancer patients. Cancer. ,vol. 55, pp. 658- 665 ,(1985) , 10.1002/1097-0142(19850201)55:3<658::AID-CNCR2820550331>3.0.CO;2-P
Diana Brinkley, J.L Haybittle, LONG-TERM SURVIVAL OF WOMEN WITH BREAST CANCER The Lancet. ,vol. 323, pp. 1118- ,(1984) , 10.1016/S0140-6736(84)92525-X
A D Hibberd, L J Horwood, J E Wells, Long term prognosis of women with breast cancer in New Zealand: study of survival to 30 years. BMJ. ,vol. 286, pp. 1777- 1779 ,(1983) , 10.1136/BMJ.286.6380.1777
A O Langlands, S J Pocock, G R Kerr, S M Gore, Long-term survival of patients with breast cancer: a study of the curability of the disease. BMJ. ,vol. 2, pp. 1247- 1251 ,(1979) , 10.1136/BMJ.2.6200.1247